All Stories

  1. Airway disease: a confusion inside an enigma
  2. Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoring
  3. Chronic cough: new insights and future prospects
  4. Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
  5. COVID-19 controversy: when to intubate?
  6. The effect of Octreotide in patients with refractory Chronic Cough
  7. Correlation and causality: a COVID-19 conundrum
  8. Editorial comment on: Global burden of COVID-19 pandemic on healthcare workers
  9. Author response: The human cough reflex has separate, distinct pathways
  10. Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity?
  11. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children
  12. The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study
  13. Multiple eosinophil counts define eosinophilic inflammation in COPD
  14. The Emerging Role of The Eosinophil and Its Measurement in Chronic Cough
  15. Pepsin in chronic cough
  16. Treating acute cough: wetversusdry – have we got the paradigm wrong?
  17. Cough hypersensitivity syndrome: clinical measurement is the key to progress